Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nucl. Med.

Sec. PET and SPECT

Volume 5 - 2025 | doi: 10.3389/fnume.2025.1569991

Quantification of neuroinflammation in spinal cord and neuroforamina of patients with painful cervical radiculopathy using [ 11 C]DPA713 PET/CT

Provisionally accepted
  • 1VU Amsterdam, Amsterdam, Netherlands
  • 2Amsterdam University Medical Center, Amsterdam, Netherlands
  • 3Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, Netherlands
  • 4Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands
  • 5Leiden University Medical Center (LUMC), Leiden, Netherlands
  • 6Elisabeth Tweesteden Hospital (ETZ), Tilburg, Netherlands
  • 7University Medical Center Groningen, Groningen, Netherlands, Netherlands

The final, formatted version of the article will be published soon.

Background: Animal models of nerve compression have revealed neuroinflammation not only at the entrapment site, but also remotely at the spinal cord. However, there is limited information on the presence of neuroinflammation in human compression neuropathies. The objectives of this study were to: (1) assess which tracer kinetic model most optimally quantified [ 11 C]DPA713 uptake in the spinal cord and neuroforamina in patients with painful cervical radiculopathy, (2) evaluate the performance of linearized methods (e.g. Logan) and simplified (e.g. standardized uptake value -SUV) methods, and (3) assess the test-retest reliability of these methods. Microglia activation associated with neuroinflammation was quantified using positron emission tomography (PET) with the radiotracer [ 11 C]DPA713, targeting the 18kDa translocator protein (TSPO). The Akaike information criterion, visual inspection of the fits and number of outliers were used to select the optimal kinetic model. As unaffected tissue, the spinal cord and neuroforamina three cervical levels above the affected target tissue was used. Results: The single tissue (1T2k) compartment model was the preferred model to describe [ 11 C]DPA713 kinetics at the spinal cord and neuroforamina. Higher levels of 1T2k VT were observed in the affected neuroforamina and spinal cord compared with corresponding unaffected tissues. Logan VT (≥0.73) showed high correlation with 1T2k VT at both locations. Of the simplified methods, neuroforamina and spinal cord SUV normalized for the metabolite corrected plasma (TBR-PP) exhibited high correlations with 1T2k VT (r≥0.84). Test-retest reliability varied between fair to excellent. Conclusions: These results indicate that a 1T2k model with metabolite corrected image derived input function can be used to describe the kinetics of [ 11 C]DPA713 in the spinal cord and neuroforamina in humans. 1T2k VT or Logan VT can be used as binding metric, while TBR-PP is the recommended choice among simplified models.

Keywords: Neuroinflammation, neuropathic pain, PET imaging, Cervical radiculopathy, Immunoactivation, PET quantification Data collection

Received: 02 Feb 2025; Accepted: 04 Aug 2025.

Copyright: © 2025 Lutke Schipholt, Koop, Scholten-Peeters, Coppieters, Boellaard, Giesen, Termeulen, Coenen, Vleggeert-Lankamp, Depauw, Berckel, Lammertsma and Yaqub. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ivo J Lutke Schipholt, VU Amsterdam, Amsterdam, Netherlands

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.